- £61.69m
- £81.71m
- £67.58m
- 94
- 63
- 12
- 58
2019 April 30th | 2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 17.4 | 24.5 | 35.1 | 49.7 | 67.6 |
Cost of Revenue | |||||
Gross Profit | 11.5 | 16.6 | 22.9 | 31.7 | 42.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 15.2 | 21 | 29.2 | 39.5 | 60.8 |
Operating Profit | 2.2 | 3.49 | 5.91 | 10.2 | 6.81 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.12 | 3.26 | 5.64 | 9.88 | 5.84 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.91 | 2.59 | 4.71 | 7.54 | 3.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1.91 | 2.59 | 4.71 | 7.54 | 3.87 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.91 | 2.59 | 4.71 | 7.54 | 3.87 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.024 | 0.027 | 0.046 | 0.073 | 0.07 |